BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
86.50
+1.00 (1.17%)
At close: Jun 9, 2026, 4:00 PM EDT
85.10
-1.40 (-1.62%)
Pre-market: Jun 10, 2026, 8:07 AM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $21.87 billion as of June 10, 2026. Its market cap has decreased by -7.79% in one year.
Market Cap
21.87B
Enterprise Value
6.42B
1-Year Change
-7.79%
Ranking
Category
Stock Price
$86.50
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $21.87B, an increase of 630.37%. That is a compound annual growth rate of 34.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 21.87B | -4.44% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 31.59B |
| Revolution Medicines | 31.57B |
| BeOne Medicines AG | 30.11B |
| Roivant Sciences | 20.49B |
| Insmed | 20.41B |
| Incyte | 20.11B |
| Moderna | 18.89B |
| Genmab | 15.27B |